Breakthrough in tuberculosis treatment: TB-PRACTECAL trial reveals efficacy of new oral regimen Post author: Post published:November 20, 2023 Post category:uncategorized The TB-PRACTECAL clinical trial outcomes, which evaluated the efficacy and safety of oral bedaquiline. You Might Also Like Scientists succeed in mapping a central part of the immune system November 24, 2023 Mapping the brain: How cell types and location influence Parkinson’s disease February 27, 2024 St. Jude announces $13 million investment to expand the understanding of G-protein coupled receptors January 18, 2024
St. Jude announces $13 million investment to expand the understanding of G-protein coupled receptors January 18, 2024